Skip to main content
. 2019 Dec 9;24(24):4498. doi: 10.3390/molecules24244498

Figure 2.

Figure 2

In vitro antiproliferative activity of (a) Coronarin D and (b) doxorubicin hydrochloride (positive control) after 48 h of treatment. Concentration range: 0.785–785 µM for Coronarin D; 0.043–43.1 µM for doxorubicin hydrochloride. Human tumor cell lines: U–251 (glioblastoma), MCF7 (breast), NCI–ADR/RES (multidrug resistant ovary), 786–0 (kidney), NCI–H460 (lung, non–small cells tumor), PC–3 (prostate), OVCAR–3 (ovary), HT–29 (colon), K562 (chronic myelogenous leukemia). Human non–tumor cell line: HaCaT (keratinocyte).